N
Neptune Medical
Developing, manufacturing, and commercializing high-volume, high clinical utility medical devices, initially focused on gastroenterology. Visit the website below for more information
About Neptune Medical
Pathfinder is a pioneering medical device company specializing in the development of a novel rigidizing overtube designed to improve the control and stability of endoscopes during gastrointestinal (GI) procedures. The company's primary product, the Pathfinder overtube, addresses the common issue of loop formation in endoscopic procedures, which can complicate and prolong diagnostic and therapeutic interventions. By allowing the overtube to toggle instantly from flexible to rigid, Pathfinder enhances the precision and ease of endoscope navigation, making it particularly valuable in complex cases involving altered anatomy.
Pathfinder serves healthcare providers and medical professionals who perform GI procedures, including luminal therapeutics and Endoscopic Retrograde Cholangiopancreatography (ERCP). The company operates within the medical device market, focusing on innovations that improve procedural outcomes and patient care. Pathfinder's business model revolves around the sale of its overtube devices to hospitals, clinics, and medical centers, generating revenue through direct sales and potential partnerships with medical equipment distributors.
The company's value proposition lies in its ability to simplify traditionally complex GI procedures, reduce procedural time, and enhance the overall effectiveness of endoscopic interventions. By providing a reliable solution to the problem of endoscope looping, Pathfinder aims to improve the efficiency and success rates of GI procedures, ultimately benefiting both healthcare providers and patients.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Burlingame, United States
- Employees
- 169
- Open positions
- 5
- Dealroom signal
- 55.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Gastroenterology, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 1 company, latest Aug 2024
- Capital deployed
- $0
- Preferred round
- CORPORATE SPINOUT
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Aug 2024 | $97M | $388M | Sonder Capital · Olympus America | ↗ |
| FundingOther financing | May 2020 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Neptune Medical is 2.4K monthly website visits, up 71.4% over the last three months. Neptune Medical's team grew 10.5% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Sonder Capital
Olympus America
Other known investors1 additional known investor
- SVSynergy Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Neptune Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Neptune Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.